Donepezil for mild cognitive impairment in Parkinson’s disease

Donepezil for mild cognitive impairment in Parkinson’s disease

Abstract We investigated the efficacy of donepezil for mild cognitive impairment in Parkinson’s disease (PD-MCI). This was a prospective, non-randomized, open-label, two-arm study. Eighty PD-MCI patients were assigned to either a treatment or control group. The treatment group received donepezil for...

Full description

Saved in:
Bibliographic Details
Main Authors: Kyoungwon Baik, Seon Myeong Kim, Jin Ho Jung, Yang Hyun Lee, Seok Jong Chung, Han Soo Yoo, Byoung Seok Ye, Phil Hyu Lee, Young H. Sohn, Seung Wan Kang, Suk Yun Kang
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/39f7c08a31db49eb80b91afbe4c66e31
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/39f7c08a31db49eb80b91afbe4c66e31

Similar Items